首页> 外国专利> CONSTRUCTION OF MITOCHONDRIAL UQCRB MUTANT EXPRESSING CELLS AND UTILIZATION OF THE CELLS FOR UQCRB ASSAY SYSTEM THEREOF

CONSTRUCTION OF MITOCHONDRIAL UQCRB MUTANT EXPRESSING CELLS AND UTILIZATION OF THE CELLS FOR UQCRB ASSAY SYSTEM THEREOF

机译:线粒体UQCRB突变体表达细胞的构建及其在UQCRB检测系统中的应用

摘要

The present invention relates to a mitochondrial UQCRB mutant cell line expressing the UQCRB mutant protein. The present invention is directed to a novel research method for UQCRB activity evaluation using a novel mitochondrial UQCRB mutant cell line, and provides a method for anticancer activity evaluation, a method for angiogenesis inhibitory activity evaluation, and a method for screening a UQCRB activity inhibitor. In particular, the cell line of the present invention is a novel cell line having cell proliferative and angiogenesis inducing activities, and provides a method for screening an angiogenesis inhibitor or an anticancer material through the UQCRB activity inhibitory mechanism, and thus can be applied in the development of therapeutic agents against angiogenesis or mitochondria-mediated diseases and various cancers.
机译:本发明涉及表达UQCRB突变蛋白的线粒体UQCRB突变细胞系。本发明针对使用新型线粒体UQCRB突变细胞系进行UQCRB活性评估的新研究方法,并且提供了用于抗癌活性评估的方法,用于血管生成抑制活性评估的方法以及用于筛选UQCRB活性抑制剂的方法。特别地,本发明的细胞系是具有细胞增殖和血管生成诱导活性的新型细胞系,并提供了通过UQCRB活性抑制机制筛选血管生成抑制剂或抗癌物质的方法,因此可以应用于开发针对血管生成或线粒体介导的疾病和各种癌症的治疗剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号